BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20920335)

  • 1. Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.
    Mezzasoma L; Antognelli C; Del Buono C; Stracci F; Cottini E; Cochetti G; Talesa VN; Mearini E
    BMC Urol; 2010 Oct; 10():17. PubMed ID: 20920335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase-associated protein Cks2 is associated with bladder cancer progression.
    Chen R; Feng C; Xu Y
    J Int Med Res; 2011; 39(2):533-40. PubMed ID: 21672358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer.
    Isurugi K; Suzuki Y; Tanji S; Fujioka T
    J Urol; 2002 Oct; 168(4 Pt 1):1574-7. PubMed ID: 12352460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.
    Cheng W; Wei Z; Gao J; Zhang Z; Ge J; Jing K; Xu F; Xie P
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):391-6. PubMed ID: 20556588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling.
    Kawakami K; Enokida H; Tachiwada T; Gotanda T; Tsuneyoshi K; Kubo H; Nishiyama K; Takiguchi M; Nakagawa M; Seki N
    Oncol Rep; 2006 Sep; 16(3):521-31. PubMed ID: 16865252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and biological significance of CDC28 protein kinase regulatory subunit 2 overexpression in human gastric cancer.
    Tanaka F; Matsuzaki S; Mimori K; Kita Y; Inoue H; Mori M
    Int J Oncol; 2011 Aug; 39(2):361-72. PubMed ID: 21617860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer.
    Weikert S; Krause H; Wolff I; Christoph F; Schrader M; Emrich T; Miller K; Müller M
    Int J Cancer; 2005 Nov; 117(2):274-80. PubMed ID: 15900578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
    Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
    Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
    Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
    Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and biological impact of cyclin-dependent kinase subunit 2 in esophageal squamous cell carcinoma.
    Kita Y; Nishizono Y; Okumura H; Uchikado Y; Sasaki K; Matsumoto M; Setoyama T; Tanoue K; Omoto I; Mori S; Owaki T; Ishigami S; Nakagawa H; Tanaka F; Mimori K; Mori M; Natsugoe S
    Oncol Rep; 2014 May; 31(5):1986-92. PubMed ID: 24604089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of the cycline kinase subunit CKS2 increases cell proliferation rate in gastric cancer.
    Kang MA; Kim JT; Kim JH; Kim SY; Kim YH; Yeom YI; Lee Y; Lee HG
    J Cancer Res Clin Oncol; 2009 Jun; 135(6):761-9. PubMed ID: 19034516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hTERT and hTR in cis reconstitutes and active human telomerase ribonucleoprotein.
    Bachand F; Kukolj G; Autexier C
    RNA; 2000 May; 6(5):778-84. PubMed ID: 10836798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma.
    Shen DY; Fang ZX; You P; Liu PG; Wang F; Huang CL; Yao XB; Chen ZX; Zhang ZY
    Liver Int; 2010 Jan; 30(1):119-25. PubMed ID: 19845855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of telomerase RNA in the plasma of patients with breast cancer, malignant melanoma or thyroid cancer.
    Novakovic S; Hocevar M; Zgajnar J; Besic N; Stegel V
    Oncol Rep; 2004 Jan; 11(1):245-52. PubMed ID: 14654933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z; Cheng H; Zhang Y; Zhou Y
    Med Sci Monit; 2021 Mar; 27():e928523. PubMed ID: 33667214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of overexpressed cyclin-dependent kinase subunits 1 and 2 in esophageal carcinoma.
    Wang JJ; Fang ZX; Ye HM; You P; Cai MJ; Duan HB; Wang F; Zhang ZY
    Dis Esophagus; 2013; 26(7):729-36. PubMed ID: 23301842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of Cks1 and Cks2 contributes to prostate tumorigenesis by promoting proliferation and inhibiting programmed cell death.
    Lan Y; Zhang Y; Wang J; Lin C; Ittmann MM; Wang F
    Int J Cancer; 2008 Aug; 123(3):543-51. PubMed ID: 18498131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and expression of human telomerase in normal and malignant cells in gastric and colon cancer patients.
    Nowak J; Januszkiewicz D; Lewandowski K; Nowicka-Kujawska K; Pernak M; Rembowska J; Nowak T; Wysocki J
    Eur J Gastroenterol Hepatol; 2003 Jan; 15(1):75-80. PubMed ID: 12544698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.